Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

GRANDE PHARMACIE MERMOZ : revenue, balance sheet and financial ratios

GRANDE PHARMACIE MERMOZ is a French company founded 9 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in PAU (64000), this company of category PME shows in 2025 a net income positive of 377 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - GRANDE PHARMACIE MERMOZ (SIREN 821740404)
Indicator 2025 2024 2023 2020 2019 2018 2017
Revenue N/C N/C N/C N/C N/C N/C N/C
Net income 376 663 € 127 007 € 858 233 € 363 304 € 235 046 € 127 418 € -28 577 €
EBITDA N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2025, GRANDE PHARMACIE MERMOZ generates positive net income of 377 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

376 663 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 87%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 39%. The balance between equity and debt is satisfactory.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

86.782%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

39.165%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

45.4%

Solvency indicators evolution
GRANDE PHARMACIE MERMOZ

Sector positioning

Debt ratio
86.78 2025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average +16 pts over 3 years

In 2025, the debt ratio of GRANDE PHARMACIE MERMOZ (86.78) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
39.16% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average -16 pts over 3 years

In 2025, the financial autonomy of GRANDE PHARMACIE MERMOZ (39.2%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 293.88. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

293.881

Liquidity indicators evolution
GRANDE PHARMACIE MERMOZ

Sector positioning

Liquidity ratio
293.88 2025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Excellent

In 2025, the liquidity ratio of GRANDE PHARMACIE MERMOZ (293.88) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Positioning of GRANDE PHARMACIE MERMOZ in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of GRANDE PHARMACIE MERMOZ is estimated at 5 983 336 € (range 4 060 320€ - 9 388 678€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
4060k€ 5983k€ 9388k€
5 983 336 € Range: 4 060 320€ - 9 388 678€
NAF 5 année 2025

Valuation method used

Net Income Multiple
376 663 € × 15.9x = 5 983 337 €
Range: 4 060 320€ - 9 388 679€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare GRANDE PHARMACIE MERMOZ with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about GRANDE PHARMACIE MERMOZ

What is the revenue of GRANDE PHARMACIE MERMOZ ?

The revenue of GRANDE PHARMACIE MERMOZ is not publicly disclosed (confidential accounts filed with INPI).

Is GRANDE PHARMACIE MERMOZ profitable?

Yes, GRANDE PHARMACIE MERMOZ generated a net profit of 377 k€ in 2025.

Where is the headquarters of GRANDE PHARMACIE MERMOZ ?

The headquarters of GRANDE PHARMACIE MERMOZ is located in PAU (64000), in the department Pyrenees-Atlantiques.

Where to find the tax return of GRANDE PHARMACIE MERMOZ ?

The tax return of GRANDE PHARMACIE MERMOZ is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does GRANDE PHARMACIE MERMOZ operate?

GRANDE PHARMACIE MERMOZ operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.